Platform Specialty Products has priced its 2.145-million share public stock offer, which was announced on Monday, at $24.50/share. The company expects to generate about $350 million in proceeds from the offer, which will go towards funding the $3.5 billion acquisition of agchems maker Arysta LifeSciences (Dublin).
展开▼
